Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 775

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

A clinical perspective of IL‐1β as the gatekeeper of inflammation

Dinarello, Charles A.·2011·European Journal of Immunology

Abstract

An expanding spectrum of acute and chronic non‐infectious inflammatory diseases is uniquely responsive to IL‐1β neutralization. IL‐1β‐mediated diseases are often called “auto‐inflammatory” and the dominant finding is the release of the active form of IL‐1β driven by endogenous molecules acting on the monocyte/macrophage. IL‐1β activity is tightly controlled and requires the conversion of the primary transcript, the inactive IL‐1β precursor, to the active cytokine by limited proteolysis. Limited proteolysis can take place extracellularly by serine proteases, released in particular by infiltrating neutrophils or intracellularly by the cysteine protease caspase‐1. Therefore, blocking IL‐1β resolves inflammation regardless of how the cytokine is released from the cell or how the precursor is cleaved. Endogenous stimulants such as oxidized fatty acids and lipoproteins, high glucose concentrations, uric acid crystals, activated complement, contents of necrotic cells, and cytokines, particularly IL‐1 itself, induce the synthesis of the inactive IL‐1β precursor, which awaits processing to the active form. Although bursts of IL‐1β precipitate acute attacks of systemic or local inflammation, IL‐1β also contributes to several chronic diseases. For example, ischemic injury, such as myocardial infarction or stroke, causes acute and extensive damage, and slowly progressive inflammatory processes take place in atherosclerosis, type 2 diabetes, osteoarthritis and smoldering myeloma. Evidence for the involvement of IL‐1β and the clinical results of reducing IL‐1β activity in this broad spectrum of inflammatory diseases are the focus of this review.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/eji.201141550

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 775

Metadata

Authors
Dinarello, C. A.
Venue
European Journal of Immunology
Publisher
Wiley
Published
2011-04-26
Volume
41
Issue
5
Pages
1203-1217
ISSN
  • 0014-2980 (ISSN-L)
  • 1521-4141
OpenAlex
W2025449580
Cited by
775
References
14
FWCI
24.33
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A clinical perspective of IL‐1β as the gatekeeper of inflammation. https://app.cochat.ai/papers/10.1002/eji.201141550
The paper
Dinarello, C. A. (2011). A clinical perspective of IL‐1β as the gatekeeper of inflammation. European Journal of Immunology. https://doi.org/10.1002/eji.201141550

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.